← Back to Bills
H.R. 3002House111th Congress (2009-2011)In Committee

PATIENTS Act of 2009

Sponsored by John A. BoehnerRep. John A. Boehner (R-OH)
Introduced June 23, 2009

Legislative Activity

Stay on top of the latest movement without scrolling through every action

4 earlier actions
HouseCommittee Latest Action

Referred to the Subcommittee on Health.

Health Subcommittee

June 24, 2009

View full timeline
HouseIntro Referral

Introduced in House

June 23, 2009

HouseIntro Referral

Referred to House Energy and Commerce

Energy and Commerce Committee

June 23, 2009

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

June 23, 2009

HouseIntro Referral

Referred to House Ways and Means

Ways and Means Committee

June 23, 2009

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

June 24, 2009

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Introduced in HouseIssued June 23, 2009

I

111th CONGRESS

1st Session

H. R. 3002

IN THE HOUSE OF REPRESENTATIVES

June 23, 2009

Mr. Boehner (for himself and Mr. Cantor) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response.

1.

Short title

This Act may be cited as the Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2009 or the PATIENTS Act of 2009.

2.

Prohibition on Certain Uses of Data Obtained from Comparative Effectiveness Research; Accounting for Personalized Medicine and Differences in Patient Treatment Response

(a)

In general

Notwithstanding any other provision of law, the Secretary of Health and Human Services—

(1)

shall not use data obtained from the conduct of comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009 (Public Law 111–5), to deny coverage of an item or service under a Federal health care program (as defined in section 1128B(f) of the Social Security Act (42 U.S.C. 1320a–7b(f))); and

(2)

shall ensure that comparative effectiveness research conducted or supported by the Federal Government accounts for factors contributing to differences in the treatment response and treatment preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.

(b)

Rule of construction

Nothing in this section shall be construed as affecting the authority of the Commissioner of Food and Drugs under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act.